Mediolanum International Funds’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249M Buy
202,670
+33,443
+20% +$34.2M 2.13% 8
2026
Q1
$150M Buy
169,227
+13,551
+9% +$13.7M 1.59% 9
2025
Q4
$168M Buy
155,676
+9,997
+7% +$9.56M 1.68% 10
2025
Q3
$106M Buy
145,679
+6,417
+5% +$4.78M 1.11% 12
2025
Q2
$108M Sell
139,262
-12,235
-8% -$9.51M 1.29% 11
2025
Q1
$125M Buy
151,497
+25,728
+20% +$21.4M 1.73% 7
2024
Q4
$97.1M Buy
125,769
+9,892
+9% +$8.19M 1.26% 11
2024
Q3
$102M Sell
115,877
-4,596
-4% -$4.13M 1.41% 10
2024
Q2
$102M Buy
120,473
+50,362
+72% +$40.3M 1.67% 9
2024
Q1
$54.6M Buy
+70,111
New +$49.9M 0.89% 18

Other funds holding LLY

Mediolanum International Funds's LLY Position: Q2 2026 in Review

Mediolanum International Funds increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $34.2M and bringing the position to 202,670 shares worth $249M. The position accounts for 2.13% of the portfolio, ranked #8.

Mediolanum International Funds first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,454 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mediolanum International Funds held 202,670 shares of Eli Lilly worth $249M as of Q2 2026.
  • Mediolanum International Funds bought 33,443 Eli Lilly shares in Q2 2026, an estimated $34.2M.
  • Eli Lilly made up 2.13% of Mediolanum International Funds's portfolio in Q2 2026, its #8 holding.
  • Mediolanum International Funds first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,454 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.